As of 2026-10-04, the Relative Valuation of G1 Therapeutics Inc (GTHX) is (17.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.15 USD, the upside of G1 Therapeutics Inc based on Relative Valuation is -344.5%.
The range of the Relative Valuation is (15.10) - (21.13) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 24.9x | 21.4x |
| Forward P/E multiples | 14.7x - 25.0x | 19.8x |
| Fair Price | (15.10) - (21.13) | (17.48) |
| Upside | -311.2% - -395.5% | -344.5% |
| Date | P/E |